A citation-based method for searching scientific literature

Rohini Roy, Jarin Chun, Simon N Powell. Nat Rev Cancer 2011
Times Cited: 791



Mark Robson, Seock-Ah Im, Elżbieta Senkus, Binghe Xu, Susan M Domchek, Norikazu Masuda, Suzette Delaloge, Wei Li, Nadine Tung, Anne Armstrong, Wenting Wu, Carsten Goessl, Sarah Runswick, Pierfranco Conte. N Engl J Med 2017
Times Cited: 1293




List of shared articles



Times cited

Homologous Recombination Deficiency Alterations in Colorectal Cancer: Clinical, Molecular, and Prognostic Implications.
Roberto Moretto, Andrew Elliott, Jian Zhang, Hiroyuki Arai, Marco Maria Germani, Veronica Conca, Joanne Xiu, Phillip Stafford, Matthew Oberley, Jim Abraham,[...]. J Natl Cancer Inst 2022
4

Sequencing of BRCA1/2-alterations using NGS-based technology: annotation as a challenge.
Silvana Ebner, Ria Winkelmann, Saskia Martin, Jens Köllermann, Peter J Wild, Melanie Demes. Oncotarget 2022
0

Molecular Characterization of BRCA1 c.5339T>C Missense Mutation in DNA Damage Response of Triple-Negative Breast Cancer.
Jeong Dong Lee, Won-Ji Ryu, Hyun Ju Han, Tae Yeong Kim, Min Hwan Kim, Joohyuk Sohn. Cancers (Basel) 2022
0

Breast Cancer-Epidemiology, Classification, Pathogenesis and Treatment (Review of Literature).
Beata Smolarz, Anna Zadrożna Nowak, Hanna Romanowicz. Cancers (Basel) 2022
0

The Fanconi anemia pathway and Breast Cancer: A comprehensive review of clinical data.
Panagiota Gianni, Evangelia Matenoglou, Georgios Geropoulos, Nirav Agrawal, Harsha Adnani, Stefanos Zafeiropoulos, Santiago J Miyara, Sara Guevara, James M Mumford, Ernesto P Molmenti,[...]. Clin Breast Cancer 2022
0

Targeting mutations in cancer.
Michael R Waarts, Aaron J Stonestrom, Young C Park, Ross L Levine. J Clin Invest 2022
0

An Overview of PARP Inhibitors for the Treatment of Breast Cancer.
Laura Cortesi, Hope S Rugo, Christian Jackisch. Target Oncol 2021
29

Emerging Therapeutic Drugs in Metastatic Triple-Negative Breast Cancer.
Élia Cipriano, Alexandra Mesquita. Breast Cancer (Auckl) 2021
8